Patent details

EP2108366 Title: Idebenone for the treatment of respiratory illness in muscular dystrophy

Basic Information

Publication number:
EP2108366
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP080070691
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Idebenone for the treatment of respiratory illness in muscular dystrophy
French Title of Invention:
Idébenone pour le traitement des maladies respiratoires dans la dystrophie musculaire
German Title of Invention:
Idebenon zur Behandlung von durch muskuläre Dystrophie vermittelten Atemwegserkrankungen
SPC Number:

Dates

Filing date:
09/04/2008
Grant date:
19/10/2011
EP Publication Date:
19/10/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/10/2009
EP B1 Publication Date:
19/10/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/04/2022
Expiration date:
09/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/04/2008
 
 

Name:
Santhera Pharmaceuticals (Schweiz) AG
Address:
Hammerstrasse 49, 4410 Liestal, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/10/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Meier Thomas
Address:
Switzerland (CH)

2

Name:
Buyse Gunnar
Address:
Belgium (BE)

Classification

Main IPC Class:
A61K 31/122;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/04/2021
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
EUROPEAN PATENT ANNUITY SERVICE GMBH
Filing date Document type Number of pages